Whitehawk Therapeutics, Inc.
WHWK- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001422142
No open-market purchases or sales by Whitehawk Therapeutics, Inc. insiders were filed in the last 90 days; 77 institutions reported holding it in 13F filings for Q2 2026, worth $198.0M in total; no superinvestor holds it.
13F holders, Q4 2025
Institutional positions in Whitehawk Therapeutics, Inc. as of Dec 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 48
- +7 vs. Q3 2025
- Shares held
- 33.0M
- +4.15M (+14.4%) vs. Q3 2025
- Total value
- $79.2M
- +$24.9M (+45.8%) vs. Q3 2025
- New holders
- 12
- 10 more added
- Sold out
- 5
- 6 more reduced
Compare with Q3 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting WHWK on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 77 | $198.0M |
| Q1 2026 | 62 | $118.2M |
| Q4 2025 | 48 | $79.2M |
| Q3 2025 | 41 | $54.3M |
| Q2 2025 | 39 | $54.6M |
| Q1 2025 | 50 | $56.2M |
| Q4 2024 | 53 | $47.2M |
| Q3 2024 | 52 | $24.7M |
| Q2 2024 | 65 | $16.7M |
| Q1 2024 | 60 | $30.9M |
| Q4 2023 | 65 | $25.8M |
| Q3 2023 | 73 | $75.3M |
| Q2 2023 | 67 | $100.8M |
| Q1 2023 | 70 | $106.6M |
| Q4 2022 | 76 | $192.2M |
| Q3 2022 | 68 | $212.1M |
| Q2 2022 | 68 | $159.3M |
| Q1 2022 | 55 | $213.8M |
| Q4 2021 | 46 | $294.2M |
| Q3 2021 | 33 | $324.1M |
| Q2 2021 | 43 | $51.0M |
| Q1 2021 | 42 | $34.3M |
Institutions, Q4 2025
Shares, value and share of portfolio for each institution holding Whitehawk Therapeutics, Inc.; share changes are against Q3 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| QVT Financial LP | 4,615,709 | $10.6M | 1.01% | 00.0% | Unchanged |
| OrbiMed Advisors LLC | 4,166,000 | $10.1M | 0.21% | 00.0% | Unchanged |
| Suvretta Capital Management, LLC | 3,700,000 | $8.95M | 0.22% | 00.0% | Unchanged |
| Acuta Capital Partners, LLC | 3,410,402 | $8.25M | 5.60% | 00.0% | Unchanged |
| Avoro Capital Advisors LLC | 2,849,402 | $6.90M | 0.07% | 00.0% | Unchanged |
| KVP Capital Advisors, LP | 2,165,997 | $5.24M | 5.41% | +2,165,997 | New |
| Siren, L.L.C. | 2,082,000 | $5.04M | 0.15% | 00.0% | Unchanged |
| Fan Yu | 2,070,000 | $5.01M | 5.43% | 00.0% | Unchanged |
| Vanguard Group Inc | 1,590,117 | $3.85M | 0.00% | +247,210+18.4% | Added |
| StemPoint Capital LP | 1,458,807 | $3.53M | 0.61% | +1,034,725+244.0% | Added |
| Acorn Capital Advisors, LLC | 1,139,363 | $2.76M | 0.93% | 00.0% | Unchanged |
| Ally Bridge Group (NY) LLC | 817,939 | $1.98M | 3.14% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 440,722 | $1.07M | 0.00% | −16,700−3.7% | Reduced |
| Geode Capital Management, LLC | 425,440 | $1.03M | 0.00% | +43,686+11.4% | Added |
| Two Sigma Investments, LP | 309,865 | $749.9K | 0.00% | +309,865 | New |
| BlackRock, Inc. | 299,011 | $723.6K | 0.00% | +2,853+1.0% | Added |
| Eversept Partners, LP | 260,259 | $629.8K | 0.04% | +260,259 | New |
| Bridgeway Capital Management, LLC | 215,284 | $521.0K | 0.01% | 00.0% | Unchanged |
| State Street Corp | 145,537 | $352.2K | 0.00% | +76,800+111.7% | Added |
| Susquehanna International Group, LLP | 110,083 | $266.4K | 0.00% | +110,083 | New |
| Northern Trust Corp | 103,452 | $250.4K | 0.00% | +31,288+43.4% | Added |
| Citadel Advisors LLC | 98,950 | $239.5K | 0.00% | −41,270−29.4% | Reduced |
| ADAR1 Capital Management, LLC | 77,593 | $187.8K | 0.01% | +77,593 | New |
| Qube Research & Technologies Ltd | 72,348 | $175.1K | 0.00% | +72,348 | New |
| Jane Street Group, LLC | 69,931 | $169.2K | 0.00% | +44,716+177.3% | Added |
| Marshall Wace, LLP | 67,959 | $164.5K | 0.00% | +67,959 | New |
| Two Sigma Advisers, LP | 42,400 | $102.6K | 0.00% | +42,400 | New |
| UBS Group AG | 29,844 | $72.2K | 0.00% | +24,151+424.2% | Added |
| Dimensional Fund Advisors LP | 28,641 | $69.3K | 0.00% | −15,474−35.1% | Reduced |
| ABG Innovation Capital Partners III GP Ltd | 26,666 | $64.5K | 100.00% | 00.0% | Unchanged |
| Acadian Asset Management LLC | 24,634 | $58.0K | 0.00% | −1,572−6.0% | Reduced |
| Prelude Capital Management, LLC | 18,796 | $45.5K | 0.00% | +18,796 | New |
| XTX Topco Ltd | 15,704 | $38.0K | 0.00% | −4,076−20.6% | Reduced |
| Quadrature Capital Ltd | 11,447 | $27.7K | 0.00% | +11,447 | New |
| Morgan Stanley | 6,748 | $16.3K | 0.00% | +4,899+265.0% | Added |
| US Bancorp | 3,333 | $8.07K | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 3,070 | $7.43K | 0.00% | 00.0% | Unchanged |
| Bartlett & Co. Wealth Management LLC | 1,333 | $3.23K | 0.00% | 00.0% | Unchanged |
| Torren Management, LLC | 1,254 | $3.04K | 0.00% | +1,254 | New |
| Bank of America Corp | 411 | $995 | 0.00% | +365+793.5% | Added |
| Russell Investments Group, Ltd. | 386 | $934 | 0.00% | 00.0% | Unchanged |
| TD Waterhouse Canada Inc. | 232 | $561 | 0.00% | 00.0% | Unchanged |
| BNP Paribas Arbitrage, SA | 160 | $387 | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 121 | $293 | 0.00% | −300−71.3% | Reduced |
| Group One Trading, L.P. | 100 | $242 | 0.00% | +100 | New |
| SBI Securities Co., Ltd. | 19 | $46 | 0.00% | 00.0% | Unchanged |
| Parallel Advisors, LLC | 8 | $19 | 0.00% | 00.0% | Unchanged |
| CWM, LLC | 25 | $0 | 0.00% | 00.0% | Unchanged |
| Peapod Lane Capital LLC | 0 | $0 | 0.00% | −303,585−100.0% | Sold out |
| Squarepoint Ops LLC | 0 | $0 | 0.00% | −83,660−100.0% | Sold out |
| Stonepine Capital Management, LLC | 0 | $0 | 0.00% | −35,253−100.0% | Sold out |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −797−100.0% | Sold out |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −35−100.0% | Sold out |